Effect of chronic blockade of angiotensin II-receptor subtypes on aortic compliance in rats with myocardial infarction

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 4, 1998, Pages 630-637

  Ceiler, Debbie L ^a,b   Nelissen Vrancken, H J Marjorie G ^a   De Mey, Jo G R ^a   Smits, Jos F M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Angiotensin receptors; Aortic compliance; Myocardial infarction; Rat; Ultrasound

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; SAPRISARTAN;

ACUTE HEART INFARCTION; ANIMAL MODEL; ARTERY COMPLIANCE; ARTICLE; B SCAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART CYCLE; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; THORACIC AORTA;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; BENZOFURANS; BLOOD PRESSURE; IMIDAZOLES; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MYOCARDIAL INFARCTION; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN;

EID: 0345563268     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199804000-00024     Document Type: Article

References (43)

1. Schunkert H, Tang S-S, Litwin SE, et al. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc Res 1993;27:731-5.
2. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 1986;4:515-24.
3. Luchner A, Stevens TL, Borgeson DD, et al. Angiotensin II in the evolution of experimental heart failure. Hypertension 1996;28:472-7.
4. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle proliferation in the normal and injured rat arterial wall. Circ Res 1991;68:450-6.
5. Griffin SA, Brown WCB, MacPherson F, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991;17:626-35.
6. Keeley FW, Elmoselhi A, Leenen FHH. Enalapril suppresses normal accumulation of elastin and collagen in cardiovascular tissues of growing rats. Am J Physiol 1992;262:H1013-21.
7. Weber KT, Janicki JS. Angiotensin and the remodeling of the myocardium. Br J Clin Pharmacol 1989;28:141-50S.
8. Smits JFM, Passier RCJJ, Nelissen-Vrancken HJMG, Kuizinga MC, Daemen MJAP. Does ACE inhibition limit structural changes in the heart following myocardial infarction? Eur Heart J 1995; 16(suppl N):46-51.
9. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF. Non-peptide angiotensin II receptor antagonists. TIPS 1991;12:55-62.
10. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and blood pressure. Hypertension 1996;27:760-5.
11. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 1995;92:10663-7.
12. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995;377:744-7.
13. Viswanathan M, Tsutsumi K, Corrrea FMA, Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 1991;179:1361-7.
14. 2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996;98:418-25.
15. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol 1997;17:257-64.
16. De Gasparo M, Rogg H, Brink M, et al. Angiotensin II receptor subtypes and cardiac function. Eur Heart J 1994;15(suppl D):98-103.
17. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995;95:46-54.
18. van Gorp A, van Ingen Schenau DS, Willigers J, et al. A technique to assess aortic distensibility and compliance in anesthetized and awake rats. Am J Physiol 1996;270:H780-6.
19. Brouwers-Ceiler DL, Nelissen-Vrancken HJMG, Smits JFM, De Mey JGR. The influence of angiotensin II-induced increase in aortic wall mass on compliance in rats in vivo. Cardiovasc Res 1997;33:478-84.
20. Schoemaker RG, Debets JJM, Struijker Boudier HAJ, Smits JFM. Delayed but not immediate captopril therapy improves cardiac function in conscious rats following myocardiai infarction. J Mol Cell Cardiol 1991;23:187-97.
21. 2 receptor ligands CGP42114 and PD123319 after blockade of the renin-angiotensin system. Eur J Pharmacol 1994;259:27-36.
22. 2 receptor subtype. New York: Plenum Press, 1994.
23. Hoeks APG, Brands PJ, Smeets FAM, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 1990;16:121-8.
24. Hoeks APG, Arts TGJ, Brands PJ, Reneman RS. Comparison of the performance of the RF cross-correlation and Doppler autocorrelation technique to estimate the mean velocity of simulated ultrasound signals. Ultrasound Med Biol 1993;19:727-40.
25. Reneman RS, van Merode T, Hick P Muytjens AMM, Hoeks APG. Age-related changes in carotid artery wall properties in men. Ultrasound Med Biol 1986;12:465-71.
26. van Krimpen C, Smits JFM, Cleutjens JPM, et al. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: effects of captopril. J Mol Cell Cardiol 1991;23:1245-53.
27. Passier RCJJ, Smits JFM, Verluyten MJA, Studer R, Drexler H, Daemen MJAP. Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol 1995;269:H1268-76.
28. Heeneman S, Leenders PJA, Aarts PJJW, et al. Peripheral vascular alterations during experimental heart failure in the rat: do they exist? Arterioscler Thromb Vasc Biol 1995;15:1503-11.
29. Gaballa MA, Raya TE, Goldman S. Large artery remodeling after myocardial infarction. Am J Physiol 1995;268:H2092-103.
30. Hirai T, Sasayama S, Kawasaki T, Yagi S-I. Stiffness of systemic arteries in patients with myocardial infarction: a noninvasive method to predict severity of coronary atherosclerosis. Circulation 1989;80:78-86.
31. Laskey WK, Parker HG, Ferrari VA, Kussmaul WG, Noordergraaf A. Estimation of total systemic arterial compliance in humans. J Appl Physiol 1990;69(1):112-9.
32. Mohiaddin RH, Underwood SR, Bogren HG, et al. Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease. Br Heart J 1989;62:90-6.
33. Timmermans PBMWM, Wong PC, et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-51.
34. Levy BI, Michel J-B, Salzmann J-L, et al. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res 1988;63:227-39.
35. Laurent S, Caviezel B, Beck L, et al. Carotid artery distensibility and distending pressure in hypertensive humans. Hypertension 1994;23:878-83.
36. Hayoz D, Rutschmann B, Perret F, et al. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension 1992;20:1-6.
37. Laurent S, Hayoz D, Trazzi S, et al. Isobaric compliance of the radial artery is increased in patients with essential hypertension. J Hypertens 1993;11:89-98.
38. 1 expression. Hypertension 1994;23:587-92.
39. 1-receptor blockade. Cardiovasc Res 1996;31:758-68.
40. Cheung B. Increased left-ventricular mass after losartan treatment. Lancet 1997;349:1743-4.
41. Casparro JM, Li P, Meggs LG, Herman MV, Anversa P. Efficacy of angiotensin-converting enzyme inhibition and AT, receptor blockade on cardiac performance after myocardial infarction in rats. J Cardiovasc Pharmacol 1994;23:584-93.
42. Raya TE, Fonken SJ, Lee RW, et al. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure. Am J Hypertens 1991;4: 334-40S.
43. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996;93:156-60.